Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy Cantor Fitzgerald

Start price
€53.40
09.10.23 / 50%
Target price
€71.08
09.10.24
Performance (%)
-9.42%
End price
€48.37
10.10.24
Summary
This prediction ended on 10.10.24 with a price of €48.37. With a performance of -9.42%, the BUY prediction by Cantor_Fitzgerald finished with a loss. A total of €2.20 was paid as dividends for this prediction. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Bristol-Myers Squibb -0.290% -0.290% -15.939%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Cantor_Fitzgerald for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Buy
Perf. (%) -9.42%
Target price 71.078
Change
Ends at 09.10.24

Bristol-Myers Squibb (NYSE: BMY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $75.00 price target on the stock.
Ratings data for BMY provided by MarketBeat

In the thread Trading Bristol-Myers Squibb
Prediction Buy
Perf. (%) -9.42%
Target price 71.078
Change
Ends at 09.10.24

Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Cantor_Fitzgerald for Bristol-Myers Squibb

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€55.30
15.09.23
€70.25
15.09.24
-20.45%
16.09.24